David Corry

Jun 21, 2023 | ncbi.nlm.nih.gov | Peter Hotez |Maria Elena Bottazzi |David Corry

2. Immune enhancement and coronavirus vaccinesBeyond direct virus-induced pathology, immune enhancement associated with eosinophilic infiltration and immunopathology is a potential safety concern linked to first-generation vaccines to prevent severe acute respiratory syndrome (SARS) [12]. A similar phenomenon may have derailed early efforts to develop an inactivated whole virus human vaccine against respiratory syncytial virus (RSV) [13].